These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2617655)

  • 1. Comparative trial of erythromycin and sulphatrimethoprim in the treatment of tetracycline-resistant Vibrio cholerae O1.
    Burans JP; Podgore J; Mansour MM; Farah AH; Abbas S; Abu-Elyazeed R; Woody JN
    Trans R Soc Trop Med Hyg; 1989; 83(6):836-8. PubMed ID: 2617655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children.
    Kabir I; Khan WA; Haider R; Mitra AK; Alam AN
    J Diarrhoeal Dis Res; 1996 Dec; 14(4):243-7. PubMed ID: 9203786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.
    Khan WA; Begum M; Salam MA; Bardhan PK; Islam MR; Mahalanabis D
    Trans R Soc Trop Med Hyg; 1995; 89(1):103-6. PubMed ID: 7747291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trial of tetracycline, chloramphenicol, and trimethoprim-sulphamethoxazole in eradication of Vibrio cholerae El Tor.
    Gharagozloo RA; Naficy K; Mouin M; Nassirzadeh MH; Yalda R
    Br Med J; 1970 Oct; 4(5730):281-2. PubMed ID: 4920226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulphamethoxazole in the treatment of cholera. Comparison with tetracycline and chloramphenicol.
    Pastore G; Rizzo G; Fera G; Schiraldi O
    Chemotherapy; 1977; 23(2):121-8. PubMed ID: 832549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania.
    Urassa WK; Mhando YB; Mhalu FS; Mjonga SJ
    East Afr Med J; 2000 Jul; 77(7):350-3. PubMed ID: 12862151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of trimethoprim-sulphamethoxazole on vibrio clearance in cholera (El Tor): a comparative study.
    Dutta JK; Santhanam S; Misra BS; Ray SN
    Trans R Soc Trop Med Hyg; 1978; 72(1):40-2. PubMed ID: 635974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh.
    Glass RI; Huq I; Alim AR; Yunus M
    J Infect Dis; 1980 Dec; 142(6):939-42. PubMed ID: 7462703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial.
    Khan WA; Saha D; Rahman A; Salam MA; Bogaerts J; Bennish ML
    Lancet; 2002 Nov; 360(9347):1722-7. PubMed ID: 12480424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children.
    Roy SK; Islam A; Ali R; Islam KE; Khan RA; Ara SH; Saifuddin NM; Fuchs GJ
    Trans R Soc Trop Med Hyg; 1998; 92(4):460-2. PubMed ID: 9850410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139.
    Khan WA; Bennish ML; Seas C; Khan EH; Ronan A; Dhar U; Busch W; Salam MA
    Lancet; 1996 Aug; 348(9023):296-300. PubMed ID: 8709688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetracycline resistant cholera in Kelantan.
    Ranjit K; Nurahan M
    Med J Malaysia; 2000 Mar; 55(1):143-5. PubMed ID: 11072502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility patterns of Vibrio cholerae isolates.
    Shrestha SD; Malla S; Adhikari BR; Shakya G; Basnyat SR; Sharma S
    JNMA J Nepal Med Assoc; 2010; 49(179):232-6. PubMed ID: 22049830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic resistance pattern of 24, 526 strains of Vibrio cholerae O1 isolated in Mexico from 1991 to 1993].
    Giono-Cerezo S; Zárate A; Gutiérrez L; Valdespino JL
    Rev Latinoam Microbiol; 1994; 36(4):257-62. PubMed ID: 7701135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin in the treatment of cholera in children.
    Bhattacharya MK; Dutta D; Ramamurthy T; Sarkar D; Singharoy A; Bhattacharya SK
    Acta Paediatr; 2003 Jun; 92(6):676-8. PubMed ID: 12856976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of nosocomial cholera in a 755-bed hospital.
    Swaddiwudhipong W; Kunasol P
    Trans R Soc Trop Med Hyg; 1989; 83(2):279-81. PubMed ID: 2514477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.
    Dupont MJ; Jouvenot M; Couetdic G; Michel-Briand Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):280-1. PubMed ID: 3885851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with enteritis in Ceará, Brazil.
    Hofer E; Reis EM; Quintaes BR; Rodrigues DP; Feitosa IS; Angelo MR; Ribeiro LH
    J Health Popul Nutr; 2001 Mar; 19(1):39-42. PubMed ID: 11394182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015.
    Dengo-Baloi LC; Semá-Baltazar CA; Manhique LV; Chitio JE; Inguane DL; Langa JP
    PLoS One; 2017; 12(8):e0181496. PubMed ID: 28792540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine.
    Chakrabarti MK; Bhattacharya MK; Bhattacharya J; Bhattacharya SK; Mahalanabis D
    Chemotherapy; 1998; 44(2):108-11. PubMed ID: 9551241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.